HeyJaredCam Watson
Deep tech strategist exploring how biotech, materials, AI & robotics move from lab to market. Based in Shanghai, leading biotech innovation at XJTLU and mentoring startups through its venture studio.
- Indexed issues, last 90 days
- 4
- Latest publication
- Sep 15, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 7, 2026
Latest issues
Getting Over Innovation Addiction (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="819" src="https://substackcdn.com/image/fetch/$s_!6HZm!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F5c7eb396-4377-463b-8aee-e749471d2dad_1672x941.png"
The Bioelectric Grid: What It Would Actually Take to Vibe Code Biology (opens the original)
Read excerpt
Part of a series on The Bioelectric Tech Stack, this piece is about what it would actually take to deploy that stack in practice, automating and coordinating each physical layer so information can move as fast and cheaply as possible, while matter stays contained until the very last, deliberate step.Vibe coding works in software because the distance between describing intent and getting a working artifact has collapsed. A model translates language into code, and that code runs almost for
Biosense and Sensibility (opens the original)
Read excerpt
This piece is part of a series on the Bioelectric Tech Stack; the infrastructure layers that determine who wins in biotech.Biology is becoming legible to machines. Slowly, unevenly, and mostly in the places where biopharma concentrates enough value to justify the effort. Everywhere else, the sensing layer remains fragmented, bespoke, and surprisingly underdeveloped for something so central to the promise of the bioeconomy.This is not a piece about models. The models are getting good. AlphaFold c
China's Bioeconomy Is Brewing Its Biggest Wave Yet (opens the original)
Read excerpt
Start with a number: 70% of the world’s fermentation capacity is in China. Not a significant share. Not a growing proportion. Seventy percent, and still growing.If you work in biotech, biopharma, specialty chemicals, or industrial biology, you live downstream of that fact whether you know it or not. The therapeutics licensing wave has been making headlines: Chinese biotechs licensing drugs to Western pharma at a pace nobody predicted five years ago. But that wave is the visible exhaust of somet
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.